Van Tıp Dergisi (Jul 2019)

Laparascopic Ventral Mesh Rectopexy Experience for Rectal Prolapse At Our Center

  • Hakan Yabanoğlu,
  • Ali Ezer,
  • İlker Murat Arer,
  • Abdirahman Sakulen Hargura,
  • Tevfik Avcı,
  • Murat Kuş

DOI
https://doi.org/10.5505/vtd.2019.70431
Journal volume & issue
Vol. 26, no. 3
pp. 309 – 314

Abstract

Read online

INTRODUCTION: Rectal prolapse, a clinical condition that causes serious social and medical problems, usually presents with costipation and incontinence. In our study we intend to present outcomes of laparoscopic ventral mesh rectopexy treatment performed at our centre. METHODS: The Files of patients who underwent laparoscopic ventral mesh rectopexy for rectal prolase between January 2015 – April 2018 at our center were retrospectively reviewed. The demographic and clinical features of a total of 26 patients were recorded. The patients who had open surgery and other surgical techniques were excluded from the study. RESULTS: Nineteen (73.1%) of the patients were female while 7 (26.9%) were male with average age of 42 (20-67). Physical examination revealed synchronous rectocele in 5 (19%) patients. Laparoscopic ventral rectopexy was performed on all the patients. Average time for the surgical procedure was 90 (50-30) minutes. Average hospital stay was 3.1 (2-4) days. Three patients had surgical site infection that was successfully managed medically. One week postoperative follow-up examination was unremarkable. One month postoperative follow-up review revealed that 23 (88.5%) patients had total relieve of compliants, while 2 (7.7%) reported partial relieve of the complaints. One (3.8%) patient reported persitence of the preoperative complaints. Average follow-up preiod was 18 (3-36) months. There was no recurrence in any of the patients. DISCUSSION AND CONCLUSION: Laparoscopic ventral mesh rectopexy is a safe and effective surgical approach for rectal prolapse. As a treatment modality it not only provides good symptomatic relief but also has acceptable recurrence rates and minimal morbidity.

Keywords